SPY303.53+4.45 1.49%
DIA255.77+5.52 2.21%
IXIC9,412.36+72.14 0.77%

HC Wainwright & Co. Reiterates Buy on Allogene Therapeutics, Raises Price Target to $42

HC Wainwright & Co. reiterates Allogene Therapeutics (NASDAQ:ALLO) with a Buy and raises the price target from $35 to $42.

Benzinga · 05/14/2020 11:35

HC Wainwright & Co. reiterates Allogene Therapeutics (NASDAQ:ALLO) with a Buy and raises the price target from $35 to $42.